Stereotactic Body Radiation Therapy for Pediatric, Adolescent, and Young Adult Patients With Osteosarcoma: Local Control Outcomes With Dosimetric Analysis
SBRT for recurrent/metastatic osteosarcoma is safe and effective, achieving a 13.6% 1-year LF rate. LFs were evenly distributed amongst in-field, marginal, and out-of-field. Spine SBRT had the highest LF risk, suggesting the need for tailored strategies near critical structures.
Authors
- Zachary D. C. Burke (ORCID: https://orcid.org/0000-0001-9601-0956)
- Jacob G. Scott (ORCID: https://orcid.org/0000-0003-2971-7673)
- A. Magnelli
- C.A. Reddy (ORCID: https://orcid.org/0000-0002-3832-8744)
- Eashwar Somasundaram (ORCID: https://orcid.org/0000-0001-8806-6992)
- S. Campbell
- Peter M. Anderson (ORCID: https://orcid.org/0000-0002-0011-0969)
- Lukas M. Nystrom (ORCID: https://orcid.org/0000-0001-8120-2680)
- Jonathan Jang
- Erin S. Murphy (ORCID: https://orcid.org/0000-0003-3724-8539)
- Matteo Trucco
- Nathan Mesko
- Jenna Kocsis
- Lilyana Angelov
Institutions
- Cleveland Clinic (US)
- Cleveland Clinic Lerner College of Medicine (US)
- Massachusetts General Hospital (US)
- The Ohio State University (US)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2026-01-14
- DOI
- https://doi.org/10.1002/1545-5017.70087
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00